831 related items for PubMed ID: 8603832
1. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G.
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
[Abstract] [Full Text] [Related]
2. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Rumble JR, Doyle AE, Cooper ME.
Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
[Abstract] [Full Text] [Related]
3. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Cooper ME, Rumble JR, Gin T, Lim-Joon T.
Clin Exp Pharmacol Physiol Suppl; 1992 Jan; 19():23-7. PubMed ID: 1395113
[Abstract] [Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
Exp Nephrol; 1994 Jan; 2(4):220-8. PubMed ID: 8069658
[Abstract] [Full Text] [Related]
5. Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats.
Silva KC, Pinto CC, Biswas SK, Souza DS, de Faria JB, de Faria JM.
Exp Eye Res; 2007 Jul; 85(1):123-9. PubMed ID: 17493613
[Abstract] [Full Text] [Related]
6. Antihypertensive effects of perindopril treatment in adult spontaneously hypertensive rats.
Lee RM, Lu M, Gillies L, Werstiuk ES.
Can J Cardiol; 1997 Sep; 13(9):831-5. PubMed ID: 9343032
[Abstract] [Full Text] [Related]
7. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
Klimas J, Vaja V, Vercinska M, Kyselovic J, Krenek P.
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
[Abstract] [Full Text] [Related]
8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[Abstract] [Full Text] [Related]
9. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL, Jespersen LT, Mulvany MJ.
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[Abstract] [Full Text] [Related]
10. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF.
J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
[Abstract] [Full Text] [Related]
11. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
Cooper ME, Rumble JR, Allen TJ, O'Brien RC, Jerums G, Doyle AE.
Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111
[Abstract] [Full Text] [Related]
12. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D, Cochain C, Loinard C, Vilar J, Mees B, Duriez M, Lévy BI, Silvestre JS.
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[Abstract] [Full Text] [Related]
13. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T, Honda T, Ohta S, Akashiba A, Takahashi T, Kameda T, Yoshii M, Minami J, Takahashi M, Ono H, Matsuoka H.
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[Abstract] [Full Text] [Related]
14. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK, Dubinion JH, Mi Z.
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[Abstract] [Full Text] [Related]
15. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC, Cooper ME, Jerums G, Doyle AE.
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[Abstract] [Full Text] [Related]
16. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[Abstract] [Full Text] [Related]
17. Interaction between an angiotensin converting enzyme inhibitor, perindopril, and a thiazide diuretic in the spontaneously hypertensive rat.
Scalbert E, Abdon D, Devissaguet M, Juggi JS.
Can J Cardiol; 1992 May; 8(4):381-6. PubMed ID: 1617521
[Abstract] [Full Text] [Related]
18. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Emonnot L, Cohen R, Lo M.
Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
[Abstract] [Full Text] [Related]
19. Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus.
Kusaka-Nakamura M, Kishi K, Miyazawa A, Yagi S, Sokabe H.
Acta Physiol Hung; 1988 Jun; 71(2):251-69. PubMed ID: 3291554
[Abstract] [Full Text] [Related]
20. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR, Shand BI, Smith AH, Robson RA, Lynn KL.
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
